Laura A Plosila

age ~78

from Queenstown, MD

Get Report
Related to:
Connected to:

Laura Plosila Phones & Addresses

  • 213 Hickory Ridge Dr, Queenstown, MD 21658 • 4103042788
  • 1008 Lake Rd, Conneaut, OH 44030 • 4405931072
  • Gaithersburg, MD
  • 242 Bellus Rd, Hinckley, OH 44233 • 3302782981
  • Cary, NC
  • Harrisburg, PA
  • Durham, NC
  • Queen Anne, MD
  • Medina, OH
  • 213 Hickory Ridge Dr, Queenstown, MD 21658 • 3304023441

Work

  • Position:
    Building and Grounds Cleaning and Maintenance Occupations

Education

  • Degree:
    Associate degree or higher

Skills

Microsoft Office

Resumes

Laura Plosila Photo 1

Laura Plosila

view source
Skills:
Microsoft Office

Us Patents

  • M. Catarrhalis

    view source
  • US Patent:
    7341727, Mar 11, 2008
  • Filed:
    May 3, 1996
  • Appl. No.:
    08/642712
  • Inventors:
    Kenneth Tucker - Germantown MD, US
    Laura Plosila - Cary NC, US
  • Assignee:
    Emergent Product Development Gaithersburg Inc. - Gaithersburg MD
  • International Classification:
    A61K 39/00
  • US Classification:
    4241901, 530324, 530328
  • Abstract:
    The invention discloses the outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to and OMP106 polypeptides and OMP106-derived polypeptides in animals.

  • Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence And Uses Thereof

    view source
  • US Patent:
    20080145916, Jun 19, 2008
  • Filed:
    Oct 26, 2007
  • Appl. No.:
    11/925586
  • Inventors:
    Kenneth Tucker - Germantown MD, US
    Laura Plosila - Cary NC, US
  • International Classification:
    C12N 1/20
    C07K 16/12
  • US Classification:
    4352521, 5303879
  • Abstract:
    The invention discloses the outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to and OMP106 polypeptides and OMP106-derived polypeptides in animals.

  • Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence And Uses Thereof

    view source
  • US Patent:
    62149814, Apr 10, 2001
  • Filed:
    Nov 12, 1997
  • Appl. No.:
    8/968685
  • Inventors:
    Kenneth Tucker - Frederick MD
    Laura Plosila - Cary NC
    Ulrich F. Tillman - Olney MD
  • Assignee:
    Antex Biologics Inc. - Gaithersburg MD
  • International Classification:
    C07H 2102
  • US Classification:
    536 231
  • Abstract:
    The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to M. catarrhalis and M. catarrhalis OMP106 polypeptides and OMP106-derived polypeptides in animals.

  • Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence And Uses Thereof

    view source
  • US Patent:
    20070087019, Apr 19, 2007
  • Filed:
    Oct 16, 2006
  • Appl. No.:
    11/580854
  • Inventors:
    Kenneth Tucker - Frederick MD, US
    Laura Plosila - Cary NC, US
    Ulrich Tillman - Mount Laurel MD, US
  • International Classification:
    A61K 39/02
    C07H 21/04
    C12N 1/21
    C07K 14/195
    C12N 15/74
  • US Classification:
    424251100, 435069300, 435252300, 435471000, 530350000, 536023700
  • Abstract:
    The invention discloses the outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to and OMP106 polypeptides and OMP106-derived polypeptides in animals.

  • Moraxella Catarrahalis Outer Membrane Protein-106 Polypeptide, Gene Sequence And Uses Thereof

    view source
  • US Patent:
    20020177200, Nov 28, 2002
  • Filed:
    Mar 20, 2001
  • Appl. No.:
    09/813214
  • Inventors:
    Kenneth Tucker - Frederick MD, US
    Laura Plosila - Cary NC, US
  • Assignee:
    Antex Biologics Inc.
  • International Classification:
    A61K039/02
    C12N009/00
    C07K016/12
  • US Classification:
    435/183000, 424/190100, 424/251100, 530/388260
  • Abstract:
    The invention discloses the Moraxella catarrhalis outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding said polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to and OMP106 polypeptides and OMP106-derived polypeptides in animals.

  • Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence And Uses Thereof

    view source
  • US Patent:
    20100021492, Jan 28, 2010
  • Filed:
    Aug 14, 2009
  • Appl. No.:
    12/541701
  • Inventors:
    Kenneth TUCKER - Frederick MD, US
    Laura PLOSILA - Cary NC, US
    Ulrich F. TILLMAN - Mount Laurel MD, US
  • International Classification:
    A61K 39/02
  • US Classification:
    4241901
  • Abstract:
    The invention discloses the outer membrane protein-106 (OMP106) polypeptide, polypeptides derived therefrom (OMP106-derived polypeptides), nucleotide sequences encoding OMP106 polypeptides, and antibodies that specifically bind the OMP106 polypeptide and/or OMP106-derived polypeptides. Also disclosed are immunogenic, prophylactic or therapeutic compositions, including vaccines, comprising OMP106 polypeptide and/or OMP 106-derived polypeptides. The invention additionally discloses methods of inducing immune responses to and OMP 106 polypeptides and OMP 106-derived polypeptides in animals.
Get Report for Laura A Plosila from Queenstown, MD, age ~78
Control profile